Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06170281 · ClinicalTrials.gov registry record · NA
Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT06170281: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT06170281 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06170281, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study will unpack the behavioral intervention for migraine and determine the optimum combinations. In addition, the study will test preference and self-selection effects during the trial.
Primary Outcome
recruitment rate, adherence rate
Interventions
- BEHAVIORAL Migraine Behavioral Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-12 |
| Est. Completion | 2028-12-01 |
| Phase | NA |
What is known before NCT06170281 opens enrollment
NCT06170281 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Migraine Behavioral Treatment is the first listed.
NCT06170281 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06170281 about?
NCT06170281 is a clinical study titled "Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial". This study will unpack the behavioral intervention for migraine and determine the optimum combinations. In addition, the study will test preference and self-selection effects during the trial.
What is the current status of trial NCT06170281?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-12. Estimated completion is 2028-12-01.
What interventions are being tested in trial NCT06170281?
The interventions under investigation include: Migraine Behavioral Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06170281?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06170281's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia